Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer

Annals of Surgical Oncology

Volumn 18, Issue 9, 2011, Pages 2604-2612

  Crumley, Andrew B C ^a   Going, James J ^a   Hilmy, Mustafa ^a   Dutta, Sumanta ^a   Tannahill, Claire ^a   McKernan, Margaret ^a   Edwards, Joanne ^a   Stuart, Robert C ^a   McMillan, Donald C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION; MACROPHAGE MIGRATION; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; STOMACH CANCER; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKOCYTES; LYMPH NODES; MACROPHAGES; MALE; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 80052701041     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1658-7     Document Type: Article

References (42)

1. Cancer Research UK Information Resource Centre. CancerStats. http://infocancerresearchukorg/cancerstats. 2004.
2. SA Hundahl JL Phillips HR Menck 2000 The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis Cancer 88 921 932 10679663 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S 1:STN:280:DC%2BD3c7ksFOiuw%3D%3D (Pubitemid 30091113)
3. GG Jamieson G Mathew R Ludemann J Wayman JC Myers PG Devitt 2004 Postoperative mortality following oesophagectomy and problems in reporting its rate Br J Surg. 91 943 947 15286953 10.1002/bjs.4596 1:STN:280: DC%2BD2czot1CjsQ%3D%3D (Pubitemid 39070806)
4. JR Siewert K Bottcher HJ Stein JD Roder 1998 Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study Ann Surg. 228 449 461 9790335 10.1097/00000658-199810000-00002 1:STN:280: DyaK1M%2FgsV2qtw%3D%3D (Pubitemid 30194389)
5. JD Roder R Busch HJ Stein U Fink JR Siewert 1994 Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus Br J Surg. 81 410 413 8173915 10.1002/bjs.1800810330 1:STN:280:DyaK2c3ivValsQ%3D%3D (Pubitemid 24124822)
6. MH Shiu M Perrotti MF Brennan 1989 Adenocarcinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors Hepatogastroenterology. 36 7 12 2744714 1:STN:280:DyaL1MzgslWgtQ%3D%3D (Pubitemid 19081944)
7. SS Robey-Cafferty AK el-Naggar AA Sahin JM Bruner JY Ro KR Cleary 1991 Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy Am J Clin Pathol. 95 844 849 2042594 1:STN:280:DyaK3M3ltlGntA%3D%3D
8. OA Khan C Alexiou I Soomro JP Duffy WE Morgan FD Beggs 2004 Pathological determinants of survival in node-negative oesophageal cancer Br J Surg. 91 1586 1591 15505868 10.1002/bjs.4778 1:STN:280:DC%2BD2cngt12gug%3D%3D (Pubitemid 39619922)
9. IB Rosenwald 2004 The role of translation in neoplastic transformation from a pathologist's point of view Oncogene. 23 3230 3247 15094773 10.1038/sj.onc.1207552 1:CAS:528:DC%2BD2cXjtFOmtr8%3D (Pubitemid 38638835)
10. DC Brown KC Gatter 2002 Ki67 protein: the immaculate deception? Histopathology. 40 2 11 11903593 10.1046/j.1365-2559.2002.01343.x 1:STN:280:DC%2BD387ntVSltQ%3D%3D (Pubitemid 34107377)
11. E Solcia C Klersy L Mastracci, et al. 2009 A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis Virchows Arch. 455 197 211 19672623 10.1007/s00428-009-0813-z 1:CAS:528:DC%2BD1MXhtFCisb7J
12. E Ressiot L Dahan A Liprandi, et al. 2008 Predictive factors of the response to chemoradiotherapy in esophageal cancer Gastroenterol Clin Biol. 32 567 577 18555630 10.1016/j.gcb.2008.02.033 1:STN:280:DC%2BD1cvnslKltw%3D%3D
13. DC McMillan 2009 Systemic inflammation, nutritional status and survival in patients with cancer Curr Opin Clin Nutr Metab Care. 12 223 226 19318937 10.1097/MCO.0b013e32832a7902
14. F Colotta P Allavena A Sica C Garlanda A Mantovani 2009 Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis. 30 1073 1081 19468060 10.1093/carcin/bgp127 1:CAS:528: DC%2BD1MXot1CisL8%3D
15. CS Roxburgh DC McMillan 2010 Role of systemic inflammatory response in predicting survival in patients with primary operable cancer Future Oncol. 6 149 163 20021215 10.2217/fon.09.136 1:CAS:528:DC%2BD1MXhsFyitL3P
16. XC Ma T Hattori R Kushima N Terata M Kodama 1994 Expression of HLA-class II antigen in gastric carcinomas. Its relationship to histopathological grade, lymphocyte infiltration and five-year survival rate Acta Oncol. 33 187 190 8204274 10.3109/02841869409098403 1:STN:280:DyaK2c3mtlGktQ%3D%3D (Pubitemid 24178961)
17. HE Lee SW Chae YJ Lee, et al. 2008 Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer Br J Cancer. 99 1704 1711 18941457 10.1038/sj.bjc.6604738 1:CAS:528:DC%2BD1cXhtlGrur%2FE
18. + T cells and natural killer cells in gastric adenocarcinoma Ann Surg Oncol. 15 1775 1782 18363071 10.1245/s10434-008-9876-3
19. S Ohno H Inagawa DK Dhar, et al. 2003 The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients Anticancer Res. 23 5015 5022 14981961 (Pubitemid 38182119)
20. + T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma Cancer Res. 63 1555 1559 12670904 1:CAS:528:DC%2BD3sXisFaitL8%3D (Pubitemid 36373643)
21. K Schumacher W Haensch C Roefzaad PM Schlag 2001 Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas Cancer Res. 61 3932 3936 11358808 1:CAS:528:DC%2BD3MXktVWqsLo%3D (Pubitemid 32720953)
22. K Klintrup JM Mäkinen S Kauppila, et al. 2005 Inflammation and prognosis in colorectal cancer Eur J Cancer. 41 2645 2654 16239109 10.1016/j.ejca.2005.07.017 (Pubitemid 41607555)
23. CS Roxburgh JM Salmond PG Horgan KA Oien DC McMillan 2009 Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer Eur J Cancer. 45 2138 2145 19409772 10.1016/j.ejca.2009.04.011
24. CS Roxburgh JM Salmond PG Horgan KA Oien DC McMillan 2009 Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer Ann Surg. 249 788 793 19387324 10.1097/SLA.0b013e3181a3e738
25. T Nozoe H Saeki K Sugimachi 2001 Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma Am J Surg. 182 197 201 11574097 10.1016/S0002-9610(01)00684-5 1:CAS:528:DC%2BD3MXntV2htL8%3D (Pubitemid 32907362)
26. H Shimada Y Nabeya S Okazumi, et al. 2003 Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma J Surg Oncol. 83 248 252 12884238 10.1002/jso.10275 (Pubitemid 36936011)
27. M Ikeda S Natsugoe S Ueno M Baba T Aikou 2003 Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma Ann Surg. 238 197 202 12894012 (Pubitemid 38174493)
28. I Gockel K Dirksen CM Messow T Junginger 2006 Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus World J Gastroenterol. 12 3746 3750 16773693 1:CAS:528: DC%2BD28Xntl2kt74%3D (Pubitemid 43950953)
29. AB Crumley DC McMillan M McKernan JJ Going CJ Shearer RC Stuart 2006 An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer Br J Cancer. 94 1568 1571 16685271 1:CAS:528:DC%2BD28XltVOmtbo%3D (Pubitemid 43924914)
30. T Kobayashi M Teruya T Kishiki, et al. 2008 Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma Surgery. 144 729 735 19081014 10.1016/j.surg.2008.08.015
31. JR Siewert HJ Stein 1998 Classification of adenocarcinoma of the oesophagogastric junction Br J Surg. 85 1457 1459 9823902 10.1046/j.1365-2168. 1998.00940.x 1:STN:280:DyaK1M%2FjvFGjug%3D%3D (Pubitemid 28502569)
32. JJ Going 1994 Efficiently estimated histologic cell counts Hum Pathol. 25 333 336 8163265 10.1016/0046-8177(94)90139-2 1:STN:280:DyaK2c3hsF2qsg%3D%3D (Pubitemid 24151116)
33. DC McMillan 2008 An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer Proc Nutr Soc. 67 257 262 18452641 10.1017/S0029665108007131
34. HE Lee MA Kim BL Lee WH Kim 2010 Low Ki-67 proliferation index is an indicator of poor prognosis in gastric cancer J Surg Oncol. 102 201 206 20740574 10.1002/jso.21583
35. JE Morley DR Thomas MM Wilson 2006 Cachexia: pathophysiology and clinical relevance Am J Clin Nutr. 83 735 743 16600922 1:CAS:528:DC%2BD28XjvFWis7g%3D (Pubitemid 44713134)
36. KC Fearon AC Voss DS Hustead 2006 Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis Am J Clin Nutr. 83 1345 1350 16762946 1:CAS:528: DC%2BD28XlvFCmtbg%3D (Pubitemid 44713065)
37. TW Du Clos C Mold 2004 C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity Immunol Res. 30 261 277 15531769 10.1385/IR:30:3:261 1:CAS:528:DC%2BD2cXhtFahu77J (Pubitemid 39546229)
38. M Krzystek-Korpacka M Matusiewicz D Diakowska, et al. 2008 Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers Clin Chem Lab Med. 46 359 364 18303990 10.1515/CCLM.2008.089 1:CAS:528:DC%2BD1cXksFaisLY%3D (Pubitemid 351317786)
39. Vashist YK, Loos J, Dedow J, et al. Glasgow prognostic score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer. Ann Surg Oncol. In press.
40. CJ Shearer JJ Going LJ Neilson RC Stuart 2007 Modified classification for adenocarcinoma of the gastro-oesophageal junction ANZ J Surg. 77 544 549 17610690 10.1111/j.1445-2197.2007.04147.x (Pubitemid 47019936)
41. KE McColl JJ Going 2010 Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia Gut. 59 282 284 20207629 10.1136/gut.2009.186825
42. MJ Proctor DS Morrison D Talwar, et al. 2011 An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study Br J Cancer. 104 726 734 21266974 10.1038/sj.bjc.6606087 1:STN:280:DC%2BC3M7psF2rtQ%3D%3D